Alaunos Therapeutics
TCRT
128 hedge funds and large institutions have $736M invested in Alaunos Therapeutics in 2015 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 44 increasing their positions, 16 reducing their positions, and 15 closing their positions.
287% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 15
216% more capital invested
Capital invested by funds: $233M → $736M (+$503M)
175% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 16
51% more funds holding
Funds holding: 85 → 128 (+43)
38% more call options, than puts
Call options by funds: $39.2M | Put options by funds: $28.4M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
+$116M |
| 2 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$29.6M |
| 3 |
O
OrbiMed
New York
|
+$25.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.4M |
| 5 |
TS
Third Security
Radford,
Virginia
|
+$14.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$13.7M |
| 2 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$3.71M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$3.13M |
| 4 |
Barclays
London,
United Kingdom
|
-$2.85M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.84M |
TCRT Hedge Fund Activity: Q1 2015 in Review
128 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q1 2015, worth a combined $736M — up 216% from $233M a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new TCRT positions and 15 closed out — a net gain of 43 holders — while 44 added to existing stakes and 16 trimmed.
The largest buyer was University of Texas/Texas AM Investment Management Co (UTIMCO), opening a new position worth an estimated $116M. The largest seller was Essex Woodlands Management, exiting entirely with an estimated $13.7M sold.
- 128 institutional investors held Alaunos Therapeutics (TCRT) as of Q1 2015, up from 85 in Q4 2014.
- Funds reported $736M of Alaunos Therapeutics stock for Q1 2015, up 216% quarter-over-quarter.
- 58 funds opened new Alaunos Therapeutics positions in Q1 2015 and 15 closed out, a net change of +43 holders.
- The largest Alaunos Therapeutics buyer in Q1 2015 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $116M added.
- The largest Alaunos Therapeutics seller in Q1 2015 was Essex Woodlands Management, an estimated $13.7M sold.
Based on aggregated 13F filings for Q1 2015.